For those who are uninsured or under-insured, CDPH will have vaccine at its three CDPH Immunization Clinics. Walk-ins are ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Moderna stock slid after the biotech company said it would slash research spending, and pause or end development of some drugs to save cash. Shares were down over 12% at $69.40 in premarket trading.

Health Canada authorized Moderna's updated COVID-19 vaccine on Tuesday to roll out in fall immunization campaigns. The federal vaccine portal lists approval of Moderna's product. Provinces and ...

But Moderna's news hasn't been as bright recently. Last month, the company revised coronavirus vaccine revenue downward due to lower sales. And in its update this week, the biotech made ...

Moderna stock slid after the biotech company said it would slash research spending, and pause or end development of some drugs to save cash. Shares were down over 12% at $69.40 in premarket trading.

(Reuters) - Moderna on Thursday said it expects sales of between $2.5 billion and $3.5 billion next year, and forecast that ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending and pushed back its time frame for breaking even. The company also ...